APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Yellow Nail Syndrome Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Yellow Nail Syndrome Treatment Market Analysis and Forecast 2026-2032

Report ID 174048380231 December 2025203 pages

Choose your research edition.

Industry ResearchYellow Nail Syndrome Treatment Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Yellow Nail Syndrome Treatment Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Yellow Nail Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Yellow Nail Syndrome Treatment Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Yellow Nail Syndrome Treatment Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Yellow Nail Syndrome Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Yellow Nail Syndrome Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Yellow Nail Syndrome Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Yellow Nail Syndrome Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Yellow Nail Syndrome Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Yellow Nail Syndrome Treatment include Abbott, Sanofi, Johnson & Johnson, Novartis, Merck, Merck, Mylan, Roche and Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Yellow Nail Syndrome Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Yellow Nail Syndrome Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Yellow Nail Syndrome Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Yellow Nail Syndrome Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Yellow Nail Syndrome Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Yellow Nail Syndrome Treatment revenue, projected growth trends, production technology, application and end-user industry.

Yellow Nail Syndrome Treatment Segment by Company

Abbott

Sanofi

Johnson & Johnson

Novartis

Merck

Merck

Mylan

Roche

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Teva Pharmaceutical

Sun Pharmaceutical

Sumitomo Corporation

Enzon Pharmaceuticals

Cipla

Allergan

Yellow Nail Syndrome Treatment Segment by Type

Capsule

Cream

Tablet

Injection

Others

Yellow Nail Syndrome Treatment Segment by Application

Hospital

Clinic

Others

Yellow Nail Syndrome Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Yellow Nail Syndrome Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Yellow Nail Syndrome Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Yellow Nail Syndrome Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Yellow Nail Syndrome Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Yellow Nail Syndrome Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Yellow Nail Syndrome Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Yellow Nail Syndrome Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Capsule Major Player Table 3. Cream Major Player Table 4. Tablet Major Player Table 5. Injection Major Player Table 6. Others Major Player Table 7. Global Yellow Nail Syndrome Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Player Table 9. Clinic Major Player Table 10. Others Major Player Table 11. Yellow Nail Syndrome Treatment Industry Trends Table 12. Yellow Nail Syndrome Treatment Industry Drivers Table 13. Yellow Nail Syndrome Treatment Industry Opportunities and Challenges Table 14. Yellow Nail Syndrome Treatment Industry Restraints Table 15. Global Yellow Nail Syndrome Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Yellow Nail Syndrome Treatment Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Yellow Nail Syndrome Treatment Market Share by Region (2021-2026) Table 18. Global Yellow Nail Syndrome Treatment Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Yellow Nail Syndrome Treatment Market Share by Region (2027-2032) Table 20. Global Yellow Nail Syndrome Treatment Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Yellow Nail Syndrome Treatment Revenue Market Share by Players (2021-2026) Table 22. Global Yellow Nail Syndrome Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Yellow Nail Syndrome Treatment Key Players Headquarters & Area Served Table 24. Global Yellow Nail Syndrome Treatment Players, Product Type & Application Table 25. Global Yellow Nail Syndrome Treatment Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Yellow Nail Syndrome Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Yellow Nail Syndrome Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Yellow Nail Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Yellow Nail Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Yellow Nail Syndrome Treatment Revenue Market Share by Type (2021-2026) Table 32. Global Yellow Nail Syndrome Treatment Revenue Market Share by Type (2027-2032) Table 33. Global Yellow Nail Syndrome Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Yellow Nail Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Yellow Nail Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Yellow Nail Syndrome Treatment Revenue Market Share by Application (2021-2026) Table 37. Global Yellow Nail Syndrome Treatment Revenue Market Share by Application (2027-2032) Table 38. Abbott Company Information Table 39. Abbott Business Overview Table 40. Abbott Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Abbott Yellow Nail Syndrome Treatment Product Portfolio Table 42. Abbott Recent Development Table 43. Sanofi Company Information Table 44. Sanofi Business Overview Table 45. Sanofi Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Sanofi Yellow Nail Syndrome Treatment Product Portfolio Table 47. Sanofi Recent Development Table 48. Johnson & Johnson Company Information Table 49. Johnson & Johnson Business Overview Table 50. Johnson & Johnson Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Johnson & Johnson Yellow Nail Syndrome Treatment Product Portfolio Table 52. Johnson & Johnson Recent Development Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Novartis Yellow Nail Syndrome Treatment Product Portfolio Table 57. Novartis Recent Development Table 58. Merck Company Information Table 59. Merck Business Overview Table 60. Merck Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Merck Yellow Nail Syndrome Treatment Product Portfolio Table 62. Merck Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Merck Yellow Nail Syndrome Treatment Product Portfolio Table 67. Merck Recent Development Table 68. Mylan Company Information Table 69. Mylan Business Overview Table 70. Mylan Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Mylan Yellow Nail Syndrome Treatment Product Portfolio Table 72. Mylan Recent Development Table 73. Roche Company Information Table 74. Roche Business Overview Table 75. Roche Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Roche Yellow Nail Syndrome Treatment Product Portfolio Table 77. Roche Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Pfizer Yellow Nail Syndrome Treatment Product Portfolio Table 82. Pfizer Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. GlaxoSmithKline Yellow Nail Syndrome Treatment Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Bayer Company Information Table 89. Bayer Business Overview Table 90. Bayer Yellow Nail Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Bayer Yellow Nail Syndrome Treatment Product Portfolio Table 92. Bayer Recent Development Table 93. AstraZeneca Company Information Table 94. AstraZeneca Business Overview Table 95. AstraZeneca Yellow Nail Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AstraZeneca Yellow Nail Syndrome Treatment Product Portfolio Table 97. AstraZeneca Recent Development Table 98. Teva Pharmaceutical Company Information Table 99. Teva Pharmaceutical Business Overview Table 100. Teva Pharmaceutical Yellow Nail Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Teva Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio Table 102. Teva Pharmaceutical Recent Development Table 103. Sun Pharmaceutical Company Information Table 104. Sun Pharmaceutical Business Overview Table 105. Sun Pharmaceutical Yellow Nail Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Sun Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio Table 107. Sun Pharmaceutical Recent Development Table 108. Sumitomo Corporation Company Information Table 109. Sumitomo Corporation Business Overview Table 110. Sumitomo Corporation Yellow Nail Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Sumitomo Corporation Yellow Nail Syndrome Treatment Product Portfolio Table 112. Sumitomo Corporation Recent Development Table 113. Enzon Pharmaceuticals Company Information Table 114. Enzon Pharmaceuticals Business Overview Table 115. Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Product Portfolio Table 117. Enzon Pharmaceuticals Recent Development Table 118. Cipla Company Information Table 119. Cipla Business Overview Table 120. Cipla Yellow Nail Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Cipla Yellow Nail Syndrome Treatment Product Portfolio Table 122. Cipla Recent Development Table 123. Allergan Company Information Table 124. Allergan Business Overview Table 125. Allergan Yellow Nail Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Allergan Yellow Nail Syndrome Treatment Product Portfolio Table 127. Allergan Recent Development Table 128. North America Yellow Nail Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 129. North America Yellow Nail Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 130. North America Yellow Nail Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 131. North America Yellow Nail Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 132. North America Yellow Nail Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. North America Yellow Nail Syndrome Treatment Revenue by Country (2021-2026) & (US$ Million) Table 134. North America Yellow Nail Syndrome Treatment Revenue by Country (US$ Million) & (2027-2032) Table 135. Europe Yellow Nail Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Yellow Nail Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Yellow Nail Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Yellow Nail Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Yellow Nail Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Yellow Nail Syndrome Treatment Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Yellow Nail Syndrome Treatment Revenue by Country (US$ Million) & (2027-2032) Table 142. China Yellow Nail Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 143. China Yellow Nail Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 144. China Yellow Nail Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 145. China Yellow Nail Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Yellow Nail Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Yellow Nail Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Yellow Nail Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Yellow Nail Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Yellow Nail Syndrome Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Asia Yellow Nail Syndrome Treatment Revenue by Region (US$ Million) & (2021-2026) Table 152. Asia Yellow Nail Syndrome Treatment Revenue by Region (US$ Million) & (2027-2032) Table 153. SAMEA Yellow Nail Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA Yellow Nail Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA Yellow Nail Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 156. SAMEA Yellow Nail Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 157. SAMEA Yellow Nail Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. SAMEA Yellow Nail Syndrome Treatment Revenue by Country (2021-2026) & (US$ Million) Table 159. SAMEA Yellow Nail Syndrome Treatment Revenue by Country (US$ Million) & (2027-2032) Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Yellow Nail Syndrome Treatment Image Figure 2. Global Yellow Nail Syndrome Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Yellow Nail Syndrome Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Capsule Image Figure 5. Cream Image Figure 6. Tablet Image Figure 7. Injection Image Figure 8. Others Image Figure 9. Global Yellow Nail Syndrome Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Yellow Nail Syndrome Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global Yellow Nail Syndrome Treatment Market Size (US$ Million) & (2021-2032) Figure 15. Global Yellow Nail Syndrome Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Yellow Nail Syndrome Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Yellow Nail Syndrome Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Yellow Nail Syndrome Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Yellow Nail Syndrome Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Yellow Nail Syndrome Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global Yellow Nail Syndrome Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Yellow Nail Syndrome Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Yellow Nail Syndrome Treatment Revenue Market Share by Application (2021-2032) Figure 25. North America Yellow Nail Syndrome Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Yellow Nail Syndrome Treatment Revenue Share by Type (2021-2032) Figure 27. North America Yellow Nail Syndrome Treatment Revenue Share by Application (2021-2032) Figure 28. North America Yellow Nail Syndrome Treatment Revenue Share by Country (2021-2032) Figure 29. United States Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Yellow Nail Syndrome Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Yellow Nail Syndrome Treatment Revenue Share by Type (2021-2032) Figure 34. Europe Yellow Nail Syndrome Treatment Revenue Share by Application (2021-2032) Figure 35. Europe Yellow Nail Syndrome Treatment Revenue Share by Country (2021-2032) Figure 36. Germany Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Yellow Nail Syndrome Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Yellow Nail Syndrome Treatment Revenue Share by Type (2021-2032) Figure 46. China Yellow Nail Syndrome Treatment Revenue Share by Application (2021-2032) Figure 47. Asia Yellow Nail Syndrome Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Yellow Nail Syndrome Treatment Revenue Share by Type (2021-2032) Figure 49. Asia Yellow Nail Syndrome Treatment Revenue Share by Application (2021-2032) Figure 50. Asia Yellow Nail Syndrome Treatment Revenue Share by Region (2021-2032) Figure 51. Japan Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Yellow Nail Syndrome Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Yellow Nail Syndrome Treatment Revenue Share by Type (2021-2032) Figure 59. SAMEA Yellow Nail Syndrome Treatment Revenue Share by Application (2021-2032) Figure 60. SAMEA Yellow Nail Syndrome Treatment Revenue Share by Country (2021-2032) Figure 61. Brazil Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Yellow Nail Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Cream
  • Tablet
  • Injection
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Merck
  • Mylan
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Sumitomo Corporation
  • Enzon Pharmaceuticals
  • Cipla
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Yellow Nail Syndrome Treatment Market by Type
  3. 1.2.1 Global Yellow Nail Syndrome Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Capsule
  5. 1.2.3 Cream
  6. 1.2.4 Tablet
  7. 1.2.5 Injection
  8. 1.2.6 Others
  9. 1.3 Yellow Nail Syndrome Treatment Market by Application
  10. 1.3.1 Global Yellow Nail Syndrome Treatment Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Yellow Nail Syndrome Treatment Market Dynamics
  1. 2.1 Yellow Nail Syndrome Treatment Industry Trends
  2. 2.2 Yellow Nail Syndrome Treatment Industry Drivers
  3. 2.3 Yellow Nail Syndrome Treatment Industry Opportunities and Challenges
  4. 2.4 Yellow Nail Syndrome Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Yellow Nail Syndrome Treatment Market Perspective (2021-2032)
  2. 3.2 Global Yellow Nail Syndrome Treatment Growth Trends by Region
  3. 3.2.1 Global Yellow Nail Syndrome Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Yellow Nail Syndrome Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Yellow Nail Syndrome Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Yellow Nail Syndrome Treatment Revenue by Players
  2. 4.1.1 Global Yellow Nail Syndrome Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Yellow Nail Syndrome Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Yellow Nail Syndrome Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Yellow Nail Syndrome Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Yellow Nail Syndrome Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Yellow Nail Syndrome Treatment Players, Product Type & Application
  8. 4.5 Global Yellow Nail Syndrome Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Yellow Nail Syndrome Treatment Market CR5 and HHI
  11. 4.6.3 2025 Yellow Nail Syndrome Treatment Tier 1, Tier 2, and Tier 3
5 Yellow Nail Syndrome Treatment Market Size by Type
  1. 5.1 Global Yellow Nail Syndrome Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Yellow Nail Syndrome Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Yellow Nail Syndrome Treatment Revenue Market Share by Type (2021-2032)
6 Yellow Nail Syndrome Treatment Market Size by Application
  1. 6.1 Global Yellow Nail Syndrome Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Yellow Nail Syndrome Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Yellow Nail Syndrome Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Yellow Nail Syndrome Treatment Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Yellow Nail Syndrome Treatment Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson Yellow Nail Syndrome Treatment Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Yellow Nail Syndrome Treatment Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Merck Yellow Nail Syndrome Treatment Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 Merck
  32. 7.6.1 Merck Company Information
  33. 7.6.2 Merck Business Overview
  34. 7.6.3 Merck Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Merck Yellow Nail Syndrome Treatment Product Portfolio
  36. 7.6.5 Merck Recent Developments
  37. 7.7 Mylan
  38. 7.7.1 Mylan Company Information
  39. 7.7.2 Mylan Business Overview
  40. 7.7.3 Mylan Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Mylan Yellow Nail Syndrome Treatment Product Portfolio
  42. 7.7.5 Mylan Recent Developments
  43. 7.8 Roche
  44. 7.8.1 Roche Company Information
  45. 7.8.2 Roche Business Overview
  46. 7.8.3 Roche Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Roche Yellow Nail Syndrome Treatment Product Portfolio
  48. 7.8.5 Roche Recent Developments
  49. 7.9 Pfizer
  50. 7.9.1 Pfizer Company Information
  51. 7.9.2 Pfizer Business Overview
  52. 7.9.3 Pfizer Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pfizer Yellow Nail Syndrome Treatment Product Portfolio
  54. 7.9.5 Pfizer Recent Developments
  55. 7.10 GlaxoSmithKline
  56. 7.10.1 GlaxoSmithKline Company Information
  57. 7.10.2 GlaxoSmithKline Business Overview
  58. 7.10.3 GlaxoSmithKline Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GlaxoSmithKline Yellow Nail Syndrome Treatment Product Portfolio
  60. 7.10.5 GlaxoSmithKline Recent Developments
  61. 7.11 Bayer
  62. 7.11.1 Bayer Company Information
  63. 7.11.2 Bayer Business Overview
  64. 7.11.3 Bayer Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Bayer Yellow Nail Syndrome Treatment Product Portfolio
  66. 7.11.5 Bayer Recent Developments
  67. 7.12 AstraZeneca
  68. 7.12.1 AstraZeneca Company Information
  69. 7.12.2 AstraZeneca Business Overview
  70. 7.12.3 AstraZeneca Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 AstraZeneca Yellow Nail Syndrome Treatment Product Portfolio
  72. 7.12.5 AstraZeneca Recent Developments
  73. 7.13 Teva Pharmaceutical
  74. 7.13.1 Teva Pharmaceutical Company Information
  75. 7.13.2 Teva Pharmaceutical Business Overview
  76. 7.13.3 Teva Pharmaceutical Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Teva Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio
  78. 7.13.5 Teva Pharmaceutical Recent Developments
  79. 7.14 Sun Pharmaceutical
  80. 7.14.1 Sun Pharmaceutical Company Information
  81. 7.14.2 Sun Pharmaceutical Business Overview
  82. 7.14.3 Sun Pharmaceutical Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Sun Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio
  84. 7.14.5 Sun Pharmaceutical Recent Developments
  85. 7.15 Sumitomo Corporation
  86. 7.15.1 Sumitomo Corporation Company Information
  87. 7.15.2 Sumitomo Corporation Business Overview
  88. 7.15.3 Sumitomo Corporation Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Sumitomo Corporation Yellow Nail Syndrome Treatment Product Portfolio
  90. 7.15.5 Sumitomo Corporation Recent Developments
  91. 7.16 Enzon Pharmaceuticals
  92. 7.16.1 Enzon Pharmaceuticals Company Information
  93. 7.16.2 Enzon Pharmaceuticals Business Overview
  94. 7.16.3 Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Product Portfolio
  96. 7.16.5 Enzon Pharmaceuticals Recent Developments
  97. 7.17 Cipla
  98. 7.17.1 Cipla Company Information
  99. 7.17.2 Cipla Business Overview
  100. 7.17.3 Cipla Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Cipla Yellow Nail Syndrome Treatment Product Portfolio
  102. 7.17.5 Cipla Recent Developments
  103. 7.18 Allergan
  104. 7.18.1 Allergan Company Information
  105. 7.18.2 Allergan Business Overview
  106. 7.18.3 Allergan Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Allergan Yellow Nail Syndrome Treatment Product Portfolio
  108. 7.18.5 Allergan Recent Developments
8 North America
  1. 8.1 North America Yellow Nail Syndrome Treatment Revenue (2021-2032)
  2. 8.2 North America Yellow Nail Syndrome Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Yellow Nail Syndrome Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Yellow Nail Syndrome Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Yellow Nail Syndrome Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Yellow Nail Syndrome Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Yellow Nail Syndrome Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Yellow Nail Syndrome Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Yellow Nail Syndrome Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Yellow Nail Syndrome Treatment Revenue by Country
  11. 8.6.1 North America Yellow Nail Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Yellow Nail Syndrome Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Yellow Nail Syndrome Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Yellow Nail Syndrome Treatment Revenue (2021-2032)
  2. 9.2 Europe Yellow Nail Syndrome Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Yellow Nail Syndrome Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Yellow Nail Syndrome Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Yellow Nail Syndrome Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Yellow Nail Syndrome Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Yellow Nail Syndrome Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Yellow Nail Syndrome Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Yellow Nail Syndrome Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Yellow Nail Syndrome Treatment Revenue by Country
  11. 9.6.1 Europe Yellow Nail Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Yellow Nail Syndrome Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Yellow Nail Syndrome Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Yellow Nail Syndrome Treatment Revenue (2021-2032)
  2. 10.2 China Yellow Nail Syndrome Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Yellow Nail Syndrome Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Yellow Nail Syndrome Treatment Revenue by Type (2027-2032)
  5. 10.3 China Yellow Nail Syndrome Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Yellow Nail Syndrome Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Yellow Nail Syndrome Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Yellow Nail Syndrome Treatment Revenue by Application (2027-2032)
  9. 10.5 China Yellow Nail Syndrome Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Yellow Nail Syndrome Treatment Revenue (2021-2032)
  2. 11.2 Asia Yellow Nail Syndrome Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Yellow Nail Syndrome Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Yellow Nail Syndrome Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Yellow Nail Syndrome Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Yellow Nail Syndrome Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Yellow Nail Syndrome Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Yellow Nail Syndrome Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Yellow Nail Syndrome Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Yellow Nail Syndrome Treatment Revenue by Country
  11. 11.6.1 Asia Yellow Nail Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Yellow Nail Syndrome Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Yellow Nail Syndrome Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Yellow Nail Syndrome Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Yellow Nail Syndrome Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Yellow Nail Syndrome Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Yellow Nail Syndrome Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Yellow Nail Syndrome Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Yellow Nail Syndrome Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Yellow Nail Syndrome Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Yellow Nail Syndrome Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Yellow Nail Syndrome Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Yellow Nail Syndrome Treatment Revenue by Country
  11. 12.6.1 SAMEA Yellow Nail Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Yellow Nail Syndrome Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Yellow Nail Syndrome Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst